{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:13:33Z","timestamp":1761110013035,"version":"3.38.0"},"reference-count":30,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1051\/medsci\/20042011973","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T15:31:06Z","timestamp":1299339066000},"page":"973-978","source":"Crossref","is-referenced-by-count":4,"title":["Calcimim\u00e9tiques et traitement des hyper-parathyro\u00efdies"],"prefix":"10.1051","volume":"20","author":[{"given":"Pablo","family":"Urena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2004,11,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Brown EM, Gamba G, Riccardi D,et al.Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid.Nature1993; 366 : 575\u201380.","DOI":"10.1038\/366575a0"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"De Luca F, Baron J. Molecular biology and clinical importance of the Ca2+-sensing receptor.Curr Opin Pediatr1998; 10 : 435\u201340.","DOI":"10.1097\/00008480-199808000-00019"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Pearce S, Steinmann B. Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism.Clin Endocrinol1999; 50 : 691\u20133.","DOI":"10.1046\/j.1365-2265.1999.00788.x"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Nemeth EF. Pharmacological regulation of parathyroid hormone secretion.Curr Pharm Des2002; 8 : 2077\u201387.","DOI":"10.2174\/1381612023393387"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Nemeth EF, Steffey ME, Hammerland LG,et al.Calcimimetics with potent and selective activity on the parathyroid calcium receptor.Proc Natl Acad SciUSA 1998; 95 : 4040\u20135.","DOI":"10.1073\/pnas.95.7.4040"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Ye C, Kanazirska M, Quinn S,et al.Modulation by polycationic Ca2+-sensing receptor agonists of nonselective cation channels in rat hippocampal neurons.Biochem Biophys Res Commun1996; 224 : 271\u201380.","DOI":"10.1006\/bbrc.1996.1019"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Fox J, Lowe SH, Petty BA, Nemeth EF. NPS R-568 : a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium.J Pharmacol Exp Ther1999; 290 : 473\u20139.","DOI":"10.1016\/S0022-3565(24)34924-9"},{"key":"R8","unstructured":"Heath H, Sanguinetti E, Oglesby S, Marriott T. Inhibition of parathyroid hormone secretionin vivoby NPS 5-568, a calcimimetic drug that targets the parathyroid cell-surface calcium receptor.Bone1995; 16 : S85."},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Lalonde RL, Gaudreault J, Karhu DA, Marriott TB. Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568.Clin Pharmacol Ther1999; 65 : 40\u20139.","DOI":"10.1016\/S0009-9236(99)70120-7"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Igarashi T, Ogata E, Maruyama K, Fukuda T. Effect of calcimimetic agent, KRN568, on gastrin secretion in healthy subjects.Endocrinol J2000; 47 : 517\u201323.","DOI":"10.1507\/endocrj.47.517"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Silverberg SJ, Bone HG, Marriott TB,et al.Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.N Engl J Med1997; 337 : 1506\u201310.","DOI":"10.1056\/NEJM199711203372104"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Shoback DM, Bilezikian JP, Turner SA,et al.The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.J ClinEndocrinol Metab2003; 88 : 5644\u20139.","DOI":"10.1210\/jc.2002-021597"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Collins MT, Skarulis MC, Bilezikian JP,et al.Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.J Clin Endocrinol Metab1998; 83 : 1083\u20138.","DOI":"10.1210\/jcem.83.4.4726"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Wada M, Furuya Y, Sakiyama J,et al.The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.J Clin Invest1997; 100 : 2977\u201383.","DOI":"10.1172\/JCI119851"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Wada M, Ishii H, Furuya Y,et al.NPS R-568 halts or reverses osteitis fibrosa in uremic rats.KidneyInt 1998; 53 : 448\u201353.","DOI":"10.1046\/j.1523-1755.1998.00782.x"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Wada M, Nagano N, Furuya Y,et al.Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism.KidneyInt 2000; 57 : 50\u20138.","DOI":"10.1046\/j.1523-1755.2000.00837.x"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Chin J, Miller SC, Wada M,et al.Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats.J Am Soc Nephrol2000; 11 : 903\u201311.","DOI":"10.1681\/ASN.V115903"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Fox J, Lowe SH, Conklin RL, Nemeth EF. The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.Endocrine1999; 10 : 97\u2013103.","DOI":"10.1385\/ENDO:10:2:97"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Ishii H, Wada M, Furuya Y,et al.Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.Bone2000; 26 : 175\u201382.","DOI":"10.1016\/S8756-3282(99)00263-X"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure.Kidney Int1998; 53 : 223\u20137.","DOI":"10.1046\/j.1523-1755.1998.00735.x"},{"key":"R21","unstructured":"Akizawa T, Suzuki M, Tominaga Y,et al.Acute effect of calcimimetic agent (CA) on hemodialysis (HD) patients with secondary hyperparathyroidism (2HPT).J Am Soc Nephrol1998; 9 : 561A."},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Goodman WG, Frazao JM, Goodkin DA,et al.A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.Kidney Int2000; 58 : 436\u201345.","DOI":"10.1046\/j.1523-1755.2000.00183.x"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Goodman WG, Hladik GA, Turner SA,et al.The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.J Am Soc Nephrol2002; 13 : 1017\u201324.","DOI":"10.1681\/ASN.V1341017"},{"key":"R24","unstructured":"Coburn J, Barri Y, Turner S,et al.Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose dependent manner in hemodialysis patients with secondary hyperparathyroidism.J Am Soc Nephrol2000; 11 : 573A."},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Lindberg J, Moe S, Goodman W,et al.The calcimimetic AMG-073 reduces parathyroid hormone (PTH), phosphorus and calcium x phosphorus product in secondary hyperparathyroidism.J Am Soc Nephrol2003; 63 : 248\u201354.","DOI":"10.1046\/j.1523-1755.2003.00720.x"},{"key":"R26","unstructured":"Drueke T, Cunningham J, Goodman W,et al.Short-term treatment of secondary hyperparathyroidism (SHTP) with the calcimimetic agent AMG 073.J Am Soc Nephrol2001; 12 : 764A."},{"key":"R27","unstructured":"Quarles L, Spiegel D, Curzi M,et al.The effects of one-year treatment with the calcimimetic AMG-073 on bone health in ESRD patients with secondary hyperparathyroidism (SHPT).J Am Soc Nephrol2002; 13 : 572A."},{"key":"R28","unstructured":"Chertow G, Danese M, McCary L, Turner S. Self-reported cognitive functioning in hemodialysis patients with secondary HPT : the effect of the calcimimetic AMG-073.J Am Soc Nephrol2002; 13 : 633A."},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Block GA, Martin KJ, de Francisco ALM,et al.Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.N Engl JMed 2004; 350 : 1516\u201325.","DOI":"10.1056\/NEJMoa031633"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Gowen M, Stroup G, Dodds R,et al.Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.J Clin Invest2000; 105 : 1595\u2013604.","DOI":"10.1172\/JCI9038"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20042011973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T08:19:45Z","timestamp":1740989985000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20042011973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":30,"journal-issue":{"issue":"11"},"alternative-id":["medsci20042011p973"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20042011973","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"type":"print","value":"0767-0974"},{"type":"electronic","value":"1958-5381"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}